According to AstraZeneca's latest financial reports the company's total assets are $101.11 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $101.11 B | 4.8% |
2022-12-31 | $96.48 B | -8.43% |
2021-12-31 | $105.36 B | 57.9% |
2020-12-31 | $66.72 B | 8.72% |
2019-12-31 | $61.37 B | 1.2% |
2018-12-31 | $60.65 B | -4.27% |
2017-12-31 | $63.35 B | 1.32% |
2016-12-31 | $62.52 B | 4.11% |
2015-12-31 | $60.05 B | 2.49% |
2014-12-31 | $58.59 B | 4.82% |
2013-12-31 | $55.89 B | 4.42% |
2012-12-31 | $53.53 B | 1.33% |
2011-12-31 | $52.83 B | -5.87% |
2010-12-31 | $56.12 B | 2.2% |
2009-12-31 | $54.92 B | 16.98% |
2008-12-31 | $46.95 B | -2.1% |
2007-12-31 | $47.95 B | 60.22% |
2006-12-31 | $29.93 B | 20.5% |
2005-12-31 | $24.84 B | -3.17% |
2004-12-31 | $25.65 B | 8.82% |
2003-12-31 | $23.57 B | 9.26% |
2002-12-31 | $21.57 B | 16.65% |
2001-12-31 | $18.49 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $167.55 B | 65.70% | ๐บ๐ธ USA |
Novartis NVS | $99.94 B | -1.16% | ๐จ๐ญ Switzerland |
Pfizer PFE | $226.50 B | 123.99% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $73.21 B | -27.60% | ๐บ๐ธ USA |
Eli Lilly LLY | $64.00 B | -36.70% | ๐บ๐ธ USA |
Sanofi SNY | $139.81 B | 38.27% | ๐ซ๐ท France |
Biogen BIIB | $26.84 B | -73.45% | ๐บ๐ธ USA |
Merck MRK | $106.67 B | 5.49% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $95.15 B | -5.89% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $75.11 B | -25.72% | ๐ฌ๐ง UK |